What is the current stock price of NLS Pharmaceutics AG (NLSP)?

As of the latest market data, NLS Pharmaceutics AG (NLSP) is trading at $2.91. The stock has seen a loss of -12.61% today.

Does NLS Pharmaceutics AG (NLSP) pay a dividend?

Based on current data, NLS Pharmaceutics AG does not have a confirmed active dividend policy.

What is the market cap of NLS Pharmaceutics AG?

The current market capitalization of NLS Pharmaceutics AG (NLSP) is approximately unavailable.

NLSP

NLS Pharmaceutics AG·Healthcare

2.91

12.613%(−0.42)

Market Closed

1.08

62.887%(−1.83)

After Hours

Last Updated: — ET

52W L: $0.7652W H: $43.40

Company Profile

NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy; and Nolazol for the treatment of ADHD. The company was incorporated in 2015 and is based in Zurich, Switzerland.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2021-01-29

Beta

0.13

Websitenlspharma.com↗